  |
Important Safety Information
Do not use NUCALA if you are allergic
to mepolizumab or any of the ingredients in NUCALA.
See full Important Safety Information below
|
|
|
|
|
| |
|
|
| |
Important Safety Information
Do not use NUCALA if you are allergic
to mepolizumab or any of the ingredients in NUCALA.
See full Important Safety Information
below
|
|
| |
Are you taking all your asthma medications but still struggling with poor symptom control, worsening asthma, ER visits, or hospitalizations? If so, your asthma may be severe and uncontrolled. But there's something that may help.
|
|
| |
NUCALA is an add-on, prescription maintenance treatment for patients 12 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
|
|
| |
DON'T JUST TREAT
YOUR ASTHMA,
TARGET IT.
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Targeted treatment starts with understanding what you're targeting—eosinophils. Eosinophils are a type of white blood cell that are a normal part of the immune system. But when there are too many, they can worsen inflammation in the airways of your lungs. About 50% of people with severe asthma have increased levels of eosinophils.
|
|
| |
|
|
| |
|
|
| |
|
|
| |
- Prevent severe asthma attacks. Studies have shown that NUCALA significantly reduced the occurrence of severe asthma attacks by more than half, even those that led to ER visits or hospitalizations.
|
|
| |
|
|
| |
- Reduce the use of oral steroids. NUCALA is NOT a steroid, and when added to your asthma medication, it helps to reduce your use of steroids like prednisone.
Your results may vary.
|
|
| |
|
|
| |
|
|
| |
Two simple actions that could change your asthma.
|
|
| |
Talk with your doctor
Prepare to talk to your doctor with this
Doctor Discussion Guide.
Take the eosinophil test
Ask your doctor for a
simple blood test to measure your eosinophil level. This will help determine if NUCALA could work for you.
Together, you and your doctor can determine if NUCALA is the next step to better manage your asthma.
|
|
| |
Important Safety Information
|
|
| |
Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA.
Do not use to treat sudden breathing problems.
NUCALA can cause serious side effects, including:
|
|
| |
- allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen after you get your injection of NUCALA. Allergic reactions can sometimes happen hours or days after you get a dose of NUCALA. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
- swelling of your face, mouth, and tongue
- breathing problems
- fainting, dizziness, feeling light-headed (low blood pressure)
- rash
- hives
|
|
| |
- Herpes zoster infections that can cause shingles have happened in people who received NUCALA.
|
|
| |
Before receiving NUCALA, tell your healthcare provider about all of your medical conditions, including if you:
|
|
| |
- are taking oral or inhaled corticosteroid medicines. Do not stop taking your other asthma medicines, including your corticosteroid medicines, unless instructed by your healthcare provider because this may cause other symptoms to come back.
- have a parasitic (helminth) infection.
- are pregnant or plan to become pregnant. It is not known if NUCALA may harm your unborn baby.
- A pregnancy registry for women who receive NUCALA while pregnant collects information about the health of you and your baby. You can talk to your healthcare provider about how to take part in this registry or you can get more information and register by calling 1-877-311-8972 or visit www.mothertobaby.org/asthma.
- are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will use NUCALA and breastfeed. You should not do both without talking with your healthcare provider first.
- are taking prescription and over-the-counter medicines, vitamins, and herbal supplements.
|
|
| |
The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and weakness (fatigue).
|
|
| |
|
|
| |
|
|
| |
Please add
sender@asthma.net
to your email address to ensure our emails reach your inbox.
This email was sent from
Asthma.net, a property of Health Union, LLC, 1 International Plaza, Suite 550 Philadelphia, PA 19113. We are sending this email to you on behalf of our sponsor; your email address has not been shared with the sponsor. To unsubscribe, click here.
©2010-19 Health Union. All rights reserved. This information is not designed to replace a physician's independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions.
Asthma.net does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our terms of use.
|
|
| |
Please do not respond to this message. Mail sent to this email address cannot be answered.
|
|
| |
This email is intended for US residents only.
|
|
| |
|
|
| |
|
|
| |
Trademarks are owned by or licensed to the GSK group of companies.
|
|
| |
|
|
| |
©2019 GSK or licensor.
MPLEML190050 May 2019
Produced in USA.
|
|
| |
|
|
|
| Are you taking all your asthma medications but still struggling with poor symptom control, worsening asthma, ER visits, or hospitalizations? If so, your asthma may be severe and uncontrolled. But there's something that may help. |
| NUCALA is an add-on, prescription maintenance treatment for patients 12 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems. |
DON'T JUST TREAT
YOUR ASTHMA,
TARGET IT.
 
|
|
What am I targeting?
Targeted treatment starts with understanding what you're targeting—eosinophils. Eosinophils are a type of white blood cell that are a normal part of the immune system. But when there are too many, they can worsen inflammation in the airways of your lungs. About 50% of people with severe asthma have increased levels of eosinophils.
|
  |
|
|
How NUCALA can help.
-
Prevent severe asthma attacks. Studies have shown that NUCALA significantly reduced the
occurrence of severe asthma attacks by more than half, even those that led to ER visits or hospitalizations.
|
|
|
- Reduce the use of oral steroids. NUCALA is NOT a steroid, and when added to your asthma medication, it helps to reduce your use of steroids like prednisone.
Your results may vary.
|
|
|
Two simple actions that could change your asthma.
Talk with your doctor
Prepare to talk to your doctor with this Doctor Discussion Guide.
Take the eosinophil test
Ask your doctor for a simple blood test to measure your eosinophil level. This will help determine if NUCALA could work for you.
|
|
Together, you and your doctor can determine if NUCALA is the next step to better manage your asthma.
|
|
Important Safety Information
Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA.
Do not use to treat sudden breathing problems.
NUCALA can cause serious side effects, including:
- allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen after you get your injection of NUCALA. Allergic reactions can sometimes happen hours or days after you get a dose of NUCALA. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
- swelling of your face, mouth, and tongue
- breathing problems
- fainting, dizziness, feeling light-headed (low blood pressure)
- rash
- hives
- Herpes zoster infections that can cause shingles have happened in people who received NUCALA.
Before receiving NUCALA, tell your healthcare provider about all of your medical conditions, including if you:
- are taking oral or inhaled corticosteroid medicines. Do not stop taking your other asthma medicines, including your corticosteroid medicines, unless instructed by your healthcare provider because this may cause other symptoms to come back.
- have a parasitic (helminth) infection.
- are pregnant or plan to become pregnant. It is not known if NUCALA may harm your unborn baby.
- A pregnancy registry for women who receive NUCALA while pregnant collects information about the health of you and your baby. You can talk to your healthcare provider about how to take part in this registry or you can get more information and register by calling 1-877-311-8972 or visit www.mothertobaby.org/asthma.
- are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will use NUCALA and breastfeed. You should not do both without talking with your healthcare provider first.
- are taking prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and weakness (fatigue).
Please see full  Prescribing Information, including
 Patient Information, for NUCALA (mepolizumab).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit  www.fda.gov/medwatch, or call 1-800-FDA-1088.
|
|
Please add
sender@asthma.net
to your email address to ensure our emails reach your inbox.
This email was sent from Asthma.net, a property of Health Union, LLC, 1 International Plaza, Suite 550 Philadelphia, PA 19113. We are sending this email to you on behalf of our sponsor; your email address has not been shared with the sponsor. To unsubscribe, click here.
©2010-19 Health Union. All rights reserved. This information is not designed to replace a physician's independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Asthma.net does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our terms of use.
|
|
Please do not respond to this message. Mail sent to this email address cannot be answered.
|
|
This email is intended for US residents only.
|
Trademarks are owned by or licensed to the GSK group of companies. |
|
 
|
©2019 GSK or licensor.
MPLEML190050 May 2019
Produced in USA.
|
|
|
